Umbilical Cord Serum Eye Drops

This study has been completed.
Sponsor:
Information provided by:
Chonnam National University Hospital
ClinicalTrials.gov Identifier:
NCT01016158
First received: November 18, 2009
Last updated: NA
Last verified: November 2009
History: No changes posted
  Purpose

In the present study, the investigators investigated the efficacy of umbilical cord serum eye drops for the treatment of patients with recurrent corneal erosions. Group A were treated with 20% umbilical cord serum eye drops 3 to 4 times a day in addition to artificial tears, and group B were treated with artificial tears only. Ophthalmic examinations including visual acuity measurement and slit lamp biomicroscopy were performed before and every month after treatment. Recurrence was defined as the presence of clinical symptoms accompanied by epithelial defects in the cornea.


Condition Intervention
Recurrent Corneal Erosion
Drug: Umbilical cord serum eyedrops

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by Chonnam National University Hospital:

Study Start Date: April 2006
Study Completion Date: October 2009
Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: umbilical cord serum eyedrops
patients with recurrent corneal erosions were treated with 20% umbilical cord serum eye drops 3 to 4 times a day in addition to artificial tears
Drug: Umbilical cord serum eyedrops
20% umbilical cord serum eye drops 3 to 4 times a day

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients with recurrent corneal erosions

Exclusion Criteria:

  • none
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01016158

Locations
Korea, Republic of
Chonnam National University Hospital
Gwang-Ju, Korea, Republic of
Sponsors and Collaborators
Chonnam National University Hospital
  More Information

Publications:
Responsible Party: Kyung-Chul Yoon
ClinicalTrials.gov Identifier: NCT01016158     History of Changes
Other Study ID Numbers: I-2009-11-135
Study First Received: November 18, 2009
Last Updated: November 18, 2009
Health Authority: Korea: Institutional Review Board

Keywords provided by Chonnam National University Hospital:
Umbilical cord serum
Recurrent corneal erosion

Additional relevant MeSH terms:
Tetrahydrozoline
Nasal Decongestants
Vasoconstrictor Agents
Cardiovascular Agents
Therapeutic Uses
Pharmacologic Actions
Respiratory System Agents
Sympathomimetics
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on July 29, 2014